ACTR5

Actin-related protein 5 · Q9H9F9 · ACTR5 on Sugi Atlas →

0 patent compounds predicted against ACTR5, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ACTR5 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Biologic Correlative Taxotere/AC PHASE2COMPLETED
A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy. PHASE1/PHASE2RECRUITING
Interleukin-2 Treatment for Wiskott-Aldrich Syndrome PHASE1COMPLETED
Evaluating MED2005 & Nitrostat Bioavailability PHASE1COMPLETED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Stress and Treatment Response in Puerto Rican Children With Asthma nanCOMPLETED
Evaluation The Effect of NB-UVB and Methotrexate on The Level of Serum Gelsolin in Psoriatic Patients nanRECRUITING
Evaluation of Vasopressin in the Vessels of Ovarian Neoplasms nanCOMPLETED
Study of the Pathophysiological Mechanisms Involved in Bleeding Events nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Genetic Characterization of Parkinson's Disease nanCOMPLETED
Family Blood Pressure Program - GenNet Network nanCOMPLETED
The Cognitive Resilience Study nanCOMPLETED
Chromosome 5Q Gene Variants and Asthma-Related Traits nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Spinal Muscular Atrophy (SMA) Biomarkers Study in the Immediate Postnatal Period of Development nanCOMPLETED
Family Blood Pressure Program - GENOA nanCOMPLETED
MRI-phenotyping of Patients With Pathogenic Anoctamin 5 Variants nanRECRUITING
Genetic Determinants of Exercise-Induced Muscle Damage (POLYGENDOMUS) nanRECRUITING
Genetic Biomarkers for the Response to Anti-VEGF (Vascular Endothelial Growth Factor).Treatment in Wet Age-related Macular Degeneration (Wet ARMD) nanCOMPLETED
Effect of Exercise on the Human Skeletal Muscle Phosphoproteome nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Mapping Novel Disease Genes for Dilated Cardiomyopathy nanCOMPLETED
Autophagy Bladder Cancer nanUNKNOWN
The Synergistic Effects of AIH and FES in Persons With MS nanACTIVE_NOT_RECRUITING
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Family Blood Pressure Program - SAPPHIRe Network nanCOMPLETED
Optical and Biochemical Biomarkers in Early Pancreatic Cancer nanCOMPLETED
Aberrant Gene Expression Prostate Carcinoma nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a ACTR5 binder may also engage these)

ProteinNameSimilarity
Q80US4 1.000 Q80US4 →
Q5ZJA4 0.997 Q5ZJA4 →
Q29RM4 0.966 Q29RM4 →
A2AWP8 0.962 A2AWP8 →
Q5R5M3 0.962 Q5R5M3 →
Q9HCE6 0.961 Q9HCE6 →
Q9Y2X7 0.961 Q9Y2X7 →
Q9NVE7 0.960 Q9NVE7 →
Q6IE70 0.959 Q6IE70 →
Q5R5F8 0.959 Q5R5F8 →
Q6ZPY2 0.958 Q6ZPY2 →
Q9Z272 0.958 Q9Z272 →
Q4R4U1 0.957 Q4R4U1 →
Q9DAK3 0.956 Q9DAK3 →
A6QL63 0.956 A6QL63 →
Q8TBP0 0.955 Q8TBP0 →
Q8CIW5 0.953 Q8CIW5 →
A5PJM7 0.953 A5PJM7 →
Q68FF6 0.953 Q68FF6 →
Q6GQW0 0.953 Q6GQW0 →
Q9UPR3 0.952 Q9UPR3 →
Q5U2R3 0.952 Q5U2R3 →
Q9P260 0.952 Q9P260 →
Q1LZF2 0.952 Q1LZF2 →
Q4V8I4 0.952 Q4V8I4 →
Q5XIS9 0.952 Q5XIS9 →
O94844 0.951 O94844 →
Q3UFK8 0.951 Q3UFK8 →
Q7Z6G3 0.951 Q7Z6G3 →
Q504Q3 0.951 Q504Q3 →